Holles Natalie C. — SEC Form 4 filings

SEC reporting owner CIK 1580111. 12 Form 4 filings on record with FilingPulse; latest filed 2026-06-24.

Transaction summary — filings shown

Covers all 12 filings on record, filed 2024-01-09 to 2026-06-24. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Third Harmonic Bio, Inc. (THRD)CEO, Director52 legs · 33,780 sh · $411,51410
Day One Biopharmaceuticals, Inc. (DAWN)Director421
Aura Biosciences, Inc. (AURA)See Remarks, Director13
LeonaBio, Inc. (LONA)Director22

Form 4 filings — Holles Natalie C.

FiledFormIssuerReported transactionsSource
2026-06-244LeonaBio, Inc. (LONA)Grant/award (A): 2,333 (derivative) @ $0EDGAR
2026-05-194Aura Biosciences, Inc. (AURA)Grant/award (A): 600,118 @ $0 · Grant/award (A): 553,844 @ $0 · Grant/award (A): 2,169,103 (derivative) @ $0EDGAR
2026-05-074LeonaBio, Inc. (LONA)Grant/award (A): 56,000 (derivative) @ $0EDGAR
2026-04-234Day One Biopharmaceuticals, Inc. (DAWN)Disposition to issuer (D): 57,310 · Disposition to issuer (D): 40,000 (derivative) · Disposition to issuer (D): 40,300 (derivative) · Disposition to issuer (D): 28,700 (derivative) · Disposition to issuer (D): 37,500 (derivative) · Disposition to issuer (D): 32,335 (derivative) · +2 moreEDGAR
2025-11-074Day One Biopharmaceuticals, Inc. (DAWN)Disposition to issuer (D): 40,000 (derivative) @ $0 · Grant/award (A): 40,000 (derivative) @ $0 · Disposition to issuer (D): 40,300 (derivative) @ $0 · Grant/award (A): 40,300 (derivative) @ $0 · Disposition to issuer (D): 28,700 (derivative) @ $0 · Grant/award (A): 28,700 (derivative) @ $0 · +4 moreEDGAR
2025-08-144Third Harmonic Bio, Inc. (THRD)Other (J): 1,218,836 · Other (J): 998,854 (derivative) @ $0 · Other (J): 50,000 (derivative) @ $0EDGAR
2025-06-044Day One Biopharmaceuticals, Inc. (DAWN)Grant/award (A): 22,500 (derivative) @ $0 · Grant/award (A): 15,000 (derivative) @ $0EDGAR
2025-01-174Third Harmonic Bio, Inc. (THRD)Grant/award (A): 400,000 (derivative) @ $0 · Grant/award (A): 50,000 (derivative) @ $0EDGAR
2024-05-284Day One Biopharmaceuticals, Inc. (DAWN)Grant/award (A): 32,335 (derivative) @ $0EDGAR
2024-05-104Third Harmonic Bio, Inc. (THRD)Option exercise (M): 20,222 @ $4.20 · Sale (S): 20,222 @ $12.18 · Option exercise (M): 20,222 (derivative) @ $0EDGAR
2024-04-154Third Harmonic Bio, Inc. (THRD)Option exercise (M): 13,558 @ $4.20 · Sale (S): 13,558 @ $12.19 · Option exercise (M): 13,558 (derivative) @ $0EDGAR
2024-01-094Third Harmonic Bio, Inc. (THRD)Grant/award (A): 396,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-09 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1580111 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →